Skip to content

Inspection Record

Lonza Portsmouth, Inc. — FDA 483 Findings

US FDAInspected 2025-06-06Published 2026-10-20 9 findingsOther quality systemAseptic processing and sterility assuranceDocumentation and recordsEnvironmental monitoringDeviation, CAPA, and investigationEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

(o) (4 Cleaning ofGrade areas used in the manufacture ofCASGEVY drug product is deficient.

2Aseptic processing and sterility assurance

Each batch of drug product purporting to be sterile and/or pyrogen-free is not adequately tested to determine conformance to such requirements.

3Documentation and records

The following practices that are inconsistent with Good Documentation Practices were observed: a.

6Aseptic processing and sterility assurance

Aseptic processing ofCASGEVY drug product is deficient.

7Deviation, CAPA, and investigation

Management of deviations and anomalous events is inadequate to identify root causes and appropriate corrective § actions.

8Equipment and facility

Heating, ventilation, and air conditioning maintenance and controls are inadequate.

9Aseptic processing and sterility assurance

Areas designed to (b) (4) in a biological safety cabinet are deficient regarding characterization and mapping of the areas and operations for aseptic processing ofdrug products.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Lonza Portsmouth, Inc. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.